Edition:
United Kingdom

People: Dermira Inc (DERM.OQ)

DERM.OQ on NASDAQ Stock Exchange Global Select Market

8.38USD
19 Jul 2019
Change (% chg)

$-0.04 (-0.48%)
Prev Close
$8.42
Open
$8.39
Day's High
$8.47
Day's Low
$8.23
Volume
130,160
Avg. Vol
436,431
52-wk High
$15.47
52-wk Low
$6.00

Horan, Christopher 

Mr. Christopher Horan is Chief Technical Operations Officer of the Company. He has served as our Chief Technical Operations Officer since April 2018. Prior to joining Dermira, Mr. Horan served approximately 14 years at Genentech, most recently as Senior Vice President of Product and Global Supply Chain Management for Roche Pharmaceuticals from May 2013 to March 2018. Mr. Horan also served as Vice President of TechOps Procurement for Roche Pharmaceuticals from July 2011 to May 2013 and Vice President of North American Supply Chain for Genentech from January 2007 to July 2011. Prior to this, he held various other positions within the operational excellence, procurement, supply chain and technical operations functions at Genentech. From 1988 to 2004, Mr. Horan worked in global roles across the engineering, manufacturing and operational excellence functions at Merck & Company, a pharmaceutical company. Mr. Horan holds a B.E. in engineering from The Stevens Institute of Technology.

Basic Compensation

Total Annual Compensation, USD 1,546,910
Restricted Stock Award, USD 811,200
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 2,358,110

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Thomas Wiggans

4,371,180

Luis Pena

2,519,500

Andrew Guggenhime

2,360,030

Christopher Horan

2,358,110

Christopher Griffith

833,154

Lori Lyons-Williams

2,704,630
As Of  31 Dec 2018